INTRODUCTION
============

Chronic obstructive pulmonary disease (COPD) is characterized by a chronic abnormal inflammatory response in the lung and an accelerated decline in lung function.^[@r01]^ In Japan, the prevalence of COPD is reportedly 10.9% among people aged \>40 years,^[@r02]^ with worldwide estimates of 8.5%--22.2%.^[@r03]^ Cigarette smoking,^[@r04]^ air pollution (such as smoke from biomass fuel),^[@r05]^ occupational exposure to toxic gas or dust,^[@r06]^ and pulmonary tuberculosis infection^[@r07]^ are all documented risk factors for COPD.

Sedentary behavior, the absence of moderate-vigorous physical activity,^[@r08]^ is known to cause poor health and is associated with cardiovascular disease, diabetes mellitus, and cancer.^[@r09],[@r10]^ Watching TV is a particularly important sedentary behavior^[@r11]^ that has been related to an increased risk of cardiovascular disease^[@r12]^ and several cancers, including lung cancer.^[@r13]^ However, whether it is associated with COPD-related mortality remains unclear. Therefore, we examined the association between the average TV viewing duration per day (daily TV viewing time) and COPD-related mortality in Japanese adults in a large-scale national cohort study.

MATERIAL AND METHODS
====================

Study population
----------------

The Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study) was established in 1988--90 and has been described in detail elsewhere.^[@r14]^ Briefly, we enrolled 110 585 apparently healthy inhabitants (46 395 men and 64 190 women) aged 40--79 years from 45 areas throughout Japan.

Data collection
---------------

Participants were recruited at the time of their health check-up and assessed using a self-administered questionnaire, and the response rate was 86%--91%. Information on the average daily TV viewing time in hours was obtained via the question, "How many hours a day, on an average, do you spend watching TV?" The average daily TV viewing time was categorized into the following three groups: \<2 hours/day, 2 to \<4 hours/day, and ≥4 hours/day. We also collected information on age, study area, smoking status, environmental tobacco smoke (ETS) exposure, body mass index (BMI; \<18.5, 18.5--24.9, or ≥25.0 kg/m^2^, or unknown), education level (junior high school, high school, college diploma, or unknown), marital status (single, married, divorced/widowed, or unknown), alcohol consumption (never, former, current alcohol drinker, or unknown), and time spent exercising (≥5, 3--4, or 1--2 hours/week, almost none, or unknown).

Smoking status was first classified as never, former, and current smoking. Never smokers were further classified by the level of ETS exposure at home or in public places, including public halls, the workplace, or public transportation (almost every day, \<4 days a week, or unknown). Former smokers were further classified by the time since they quit (≥10 or \<10 years, or unknown). Current smokers were further classified by the number of pack years (≥20 or \<20 pack years, or unknown). BMI was calculated with self-reported height and weight.

Follow-up
---------

The dates and causes of death of participants were confirmed by death certificates and coded according to the Tenth Revision of the International Classification of Disease (ICD-10). The primary outcome in the present study was the underlying cause of death in patients with COPD (J41--44 or J47). The overall study design was approved by the Ethics Review Committee of Nagoya University School of Medicine.

Statistical analysis
--------------------

Sex-specific multivariate hazard ratios (HRs) and confidence intervals (CIs) for COPD-related mortality were calculated using a Cox proportional hazards model. Age (as a continuous variable), study area, smoking status, ETS exposure, BMI, educational level, marital status, alcohol consumption, and exercise time were included in the multivariate models. We also conducted additional analysis to assess the associations between the average daily TV viewing time in hours and the risk of COPD-related mortality. Analyses were repeated by restricting to current smokers and by excluding participants who died or were censored within 5 years from the study baseline. An alpha level of 0.05 was considered statistically significant. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).

RESULTS
=======

Of the 110 585 original cohort members, 8909 participants were excluded because they had a medical history of cancer, stroke, myocardial infarction, or tuberculosis at baseline. An additional 14 669 participants from 5 areas were excluded because their questionnaires did not include the specified question. In addition, we excluded a further 7521 and 2798 participants with data missing for smoking status and average daily TV viewing times, respectively. Accordingly, 76 688 participants (33 414 men and 43 274 women) were analyzed in the present study. Participants who moved out from the study area during the study period were treated as censored cases (*n* = 2976).

The mean (standard deviation \[SD\]) age of participants at baseline was 56.9 (10.1) years (males: 56.7 \[10.1\] years; females: 57.0 \[10.1\] years). Table [1](#tbl01){ref-type="table"} summarizes the baseline characteristics of participants according to the average daily TV viewing time. Compared with men and women who viewed TV for \<2 hours/day, those who viewed TV for ≥4 hours/day tended to be older, were more likely to be a smoker and less likely to have a normal BMI or college diploma. Men who viewed TV for \>4 hours/day were more likely to be married and less likely to be current drinkers than men who viewed TV for \<2 hours/day. The opposite was true for women.

###### Baseline characteristics of participants by television viewing duration

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                      Category                  Males           Females                                                       
  ----------------------------------- ------------------------- --------------- --------------- ------------- --------------- --------------- -------------
  Age (SD), years                                               55.5 (10.3)     56.1 (9.9)      60.0 (10.0)   55.0 (10.3)     56.4 (9.8)      59.8 (9.7)

  Smoking status                                                                                                                               

   Never smokers' exposure to\        Less than 4 days a week   444 (6.7)       1082 (5.4)      219 (3.2)     2867 (32.5)     7854 (33.8)     3092 (27.6)
   ETS at home or in public places                                                                                                            

  Almost everyday                     297 (4.5)                 871 (4.4)       297 (4.4)       1360 (15.5)   4458 (19.1)     2343 (20.9)     

  Unknown                             1000 (15.0)               2157 (10.8)     602 (8.9)       4200 (47.6)   9616 (41.3)     4679 (41.8)     

   Former smoker                      Quit ≥10 years ago        754 (11.4)      2590 (12.9)     918 (13.6)    47 (0.5)        157 (0.7)       138 (1.2)

  Quit \<10 years ago                 725 (11.0)                2206 (11.0)     803 (11.9)      35 (0.4)      102 (0.4)       77 (0.7)        

  Unknown                             43 (0.7)                  137 (0.7)       45 (0.7)        7 (0.1)       18 (0.1)        19 (0.2)        

   Current smoker                     \<20 pack years           6 (0.1)         12 (0.1)        4 (0.1)       3 (0.1)         8 (0.1)         9 (0.1)

  ≥20 pack years                      3314 (49.9)               10 829 (54.1)   3827 (56.4)     269 (3.1)     1008 (4.3)      819 (7.3)       

  Unknown                             49 (0.7)                  129 (0.6)       54 (0.8)        16 (0.2)      46 (0.2)        27 (0.2)        

  Body mass index (kg/m^2^)           \<18.5                    334 (5.3)       868 (4.5)       410 (6.4)     594 (7.1)       1283 (5.8)      609 (5.8)

  18.5--24.9                          4816 (76.8)               14 431 (75.2)   4701 (73.3)     6137 (73.3)   15 813 (70.9)   7025 (66.4)     

  ≥25.0                               1123 (17.9)               3892 (20.3)     1303 (20.3)     1637 (19.6)   5204 (23.3)     2939 (27.8)     

  College education                   Yes                       3849 (58.0)     11 881 (59.4)   3706 (54.8)   5681 (64.5)     14 685 (63.1)   6441 (57.5)

  Married                             Yes                       5213 (78.6)     17 240 (86.1)   5524 (81.6)   6502 (73.9)     18 477 (79.4)   7936 (70.8)

  Current alcohol drinker             Yes                       5085 (76.7)     14 972 (74.8)   4414 (65.2)   1810 (20.6)     4933 (21.2)     2458 (21.9)

  Weekly exercise time (hours/week)   ≥5                        357 (6.3)       1348 (7.1)      482 (7.5)     338 (4.5)       950 (4.3)       490 (4.7)

  3--4                                358 (6.4)                 1395 (7.3)      452 (7.1)       352 (4.7)     1188 (5.4)      619 (5.9)       

  1--2                                987 (17.5)                3290 (17.2)     988 (15.4)      969 (12.8)    3075 (14.0)     1454 (13.9)     

  Almost none                         3937 (69.8)               13 074 (68.4)   4484 (70.0)     5902 (78.0)   16 803 (76.3)   7881 (75.5)     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

Values are expressed as mean ± standard deviation or number (%).

ETS, environmental tobacco smoke; SD, standard deviation.

During the median follow-up period of 19.4 years, 278 participants (244 men and 34 women) died of COPD. Of the original population, 4415 participants left the study area and 17 283 participants died from causes other than COPD. The HRs for COPD-related mortality associated with the average daily TV viewing time are shown in Table [2](#tbl02){ref-type="table"}. Compared with men who watched TV for less than 2 hours/day, those who watched TV for more than 4 hours/day were more likely to die of COPD (HR 1.63; 95% CI, 1.04--2.55). This finding was independent of age, study area, smoking status, BMI, education, marital status, alcohol consumption, and exercise time. The average daily TV viewing time was linearly and positively associated with COPD-related mortality (*P* = 0.04). Similarly, elevated HRs were observed in a sensitivity analysis that excluded participants who died or were censored within 5 years of the study baseline (HR 1.68; 95% CI, 1.03--2.74) and in an analysis restricted to men who were current smokers (HR 1.70; 95% CI, 0.98--2.97). However, the average daily TV viewing time was not associated with COPD-related mortality in women.

###### Hazard ratios for chronic obstructive pulmonary disease-related mortality associated with television viewing duration

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Television viewing time\                                                            Person-years   Cases   Age and study area\    Multivariate HR\      Multivariate HR\
  (hours/day)                                                                                                adjusted HR (95% CI)   (95% CI)^a^           (95% CI)^b^
  ----------------------------------------------------------------------------------- -------------- ------- ---------------------- --------------------- ---------------------
  Men                                                                                                                                                      

   \<2                                                                                109 892        35      ref                    ref                   ref

   ≥2 to \<4                                                                          327 148        136     1.51 (1.03--2.20)\*    1.37 (0.93--2.00)     1.40 (0.92--2.14)

   ≥4                                                                                 100 167        73      1.87 (1.23--2.82)\*    1.63 (1.08--2.47)\*   1.63 (1.04--2.55)\*

   *P* for trend                                                                                             0.005                  0.02                  0.04

  Women                                                                                                                                                    

   \<2                                                                                153 031        6       ref                    ref                   ref

   ≥2 to \<4                                                                          398 006        18      1.18 (0.46--3.10)      1.08 (0.41--2.80)     1.03 (0.40--2.75)

   ≥4                                                                                 178 265        10      1.00 (0.35--2.88)      0.85 (0.30--2.45)     0.84 (0.29--2.48)

   *P* for trend                                                                                             0.43                   0.89                  0.35

  **For current smokers**                                                                                                                                 

  Men                                                                                                                                                      

   \<2                                                                                55 528         23      ref                                          ref

   ≥2 to \<4                                                                          178 255        91      1.35 (0.85--2.16)                            1.37 (0.82--2.30)

   ≥4                                                                                 57 983         50      1.68 (1.01--2.75)\*                          1.70 (0.98--2.97)

   *P* for trend                                                                                             0.09                                         0.13

  Women                                                                                                                                                    

   \<2                                                                                4871           1       ref                                          ref

   ≥2 to \<4                                                                          17 467         3       0.71 (0.06--7.51)                            0.44 (0.03--6.63)

   ≥4                                                                                 12 728         3       0.91 (0.08--9.83)                            1.14 (0.09--15.34)

   *P* for trend                                                                                             0.18                                         0.93

  **Excluding participants who died or were censored within 5 years from baseline**                                                                       

  Men                                                                                                                                                      

   \<2                                                                                108 921        31      ref                    ref                   ref

   ≥2 to \<4                                                                          324 101        128     1.62 (1.08--2.42)      1.46 (0.97--2.18)     1.53 (0.97--2.40)

   ≥4                                                                                 98 552         64      1.89 (1.22--2.94)\*    1.67 (1.06--2.56)\*   1.68 (1.03--2.74)\*

   *P* for trend                                                                                             0.01                   0.06                  0.09

  Women                                                                                                                                                    

   \<2                                                                                152 244        6       ref                    ref                   ref

   ≥2 to \<4                                                                          396 192        16      0.98 (0.37--2.61)      0.90 (0.34--2.38)     0.91 (0.33--2.47)

   ≥4                                                                                 176 663        9       0.85 (0.29--2.50)      0.72 (0.24--2.11)     0.75 (0.25--2.28)

   *P* for trend                                                                                             0.38                   0.23                  0.33
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HR, hazard ratio; CI, confidence interval.

\**P* \< 0.05.

^a^Adjusted for age, study area, and smoking status (never smokers: exposure to environmental tobacco smoke at home or in public places almost every day or less or unknown, former smokers: time since quitting ≥10 or \<10 years or unknown, and current smokers: ≥20 or \<20 pack years or unknown).

^b^Further adjusted for body mass index (\<18.5, 18.5--24.9, or ≥25.0 kg/m^2^ or unknown), education (junior high school, high school, college diploma, or unknown), marital status (single, married, divorced/widowed, or unknown), alcohol drinking (never, former, current alcohol drinker, or unknown), exercise time (≥5, 3--4, 1--2 hours/week, almost none, or unknown). Smoking status was not adjusted for in current smokers. *P* for trend: associations between the original continuous variables of daily hours spent watching television and risk of chronic obstructive pulmonary disease-related mortality.

DISCUSSION
==========

In this large cohort study, we found that a longer average daily TV viewing time was associated with an increased risk of mortality among Japanese men with COPD after adjusting for potential confounders. This association persisted even after excluding participants who died from other causes or were censored. However, similar associations did not exist among women.

To our knowledge, this is the first report to investigate the association between the average daily TV viewing time and COPD-related mortality. The associations were similar to those in a previous study that reported prolonged daily TV viewing time as a risk factor for lung cancer.^[@r13]^ COPD is characterized by a chronic abnormal inflammatory response in the lung.^[@r01]^ Although potential mechanisms underlying the increase in COPD-related mortality with an increase in the average daily TV viewing time remain unclear, we assume that it is the sedentary nature of watching TV. Consistent with this theory, a longer average daily TV viewing time is reported to be a marker of sedentary behavior,^[@r15]^ and prolonged sedentary behavior has been shown to increase the inflammatory factors interleukin-6, tumor necrosis factor-alpha, and leptin,^[@r16],[@r17]^ all of which are known to be risk factors for susceptibility to lung function impairment.^[@r18]--[@r20]^ Sedentary behavior also causes metabolic dysfunction,^[@r21]^ which can lead to hyperinsulinemia that can modify cell differentiation, apoptosis, and proliferation.^[@r22]^ These factors may contribute to lung dysfunction; however, further biological or epidemiological studies are needed to clarify this issue.

In this study, estimated HRs were comparable among analyses of all male participants and those restricted to current male smokers. However, none of the associations reached statistical significance. We consider this result to be due to the lack of statistical power.

We found an association between COPD-related mortality and average daily TV viewing time for male participants only. This may be related to the fact that men reportedly only spend 1 hour/day on housework, whereas women reportedly spend 4 to 5 hours/day on housework, with more than 1.3 hours/day spent on housework completed while watching TV.^[@r23]^ Therefore, sedentary time may be overestimated, and the average daily TV viewing time may not be an appropriate indicator of sedentary behavior for women in Japan.

The major strengths of this study are its prospective cohort design, the inclusion of participants from throughout Japan, and its long follow-up period. However, several limitations should be noted. First, we obtained information on the average daily TV viewing time through self-reporting that was not validated; therefore, some misclassification may have been included in our results. However, this would have occurred randomly because participants could not foresee subsequent events at baseline. Accordingly, such an error may have diminished the estimated HR. Second, some participants with COPD at baseline might be included in this cohort; therefore, a potential reverse relationship between COPD and sedentary behavior could have been present. However, exclusion of participants who died or were censored within 5 years of the study baseline did not materially affect the results. In addition, information on potential confounders for COPD was collected at baseline and adjusted as much as possible in the analysis. Third, sedentary behavior is characterized by an energy expenditure less than 1.5 multiples of the basal metabolic rate, including activities such as computer use, occupational sitting, reading, and driving a car^[@r24]^; therefore, TV viewing time is not always a good indicator of total sedentary time. Using an objective measurement, such as an accelerometer, would make our results more robust.^[@r25]^

In conclusion, this cohort study indicated that an average daily TV viewing time of \>4 hours/day was associated with an increased risk of COPD-related mortality among men aged 40--79 years in Japan compared with the risk associated with a viewing time of \<2 hours/day. Our findings suggest that avoiding a sedentary lifestyle by decreasing the average daily TV viewing time may help in preventing death from COPD among men.
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